Genocea to Host Second Quarter 2020 Corporate Update Conference Call & Webcast
CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, […]